Quantcast
Last updated on April 24, 2014 at 17:35 EDT

Latest Bone Stories

2013-11-07 08:32:26

LONDON, Nov. 7, 2013 /PRNewswire/ -- Smith & Nephew (NYSE:SNN;LSE:SN), the global medical technology business, announced the US launch of the HEALICOIL(TM)( )REGENESORB Suture Anchor at today's Arthroscopy Association of North America (AANA) Fall Course in Las Vegas. Building on the success of the innovative HEALICOIL PK design, this new suture anchor is the first device to use the company's proprietary REGENESORB material - an advanced biocomposite that has been shown in...

2013-10-29 08:34:31

LUND, Sweden, Oct. 29, 2013 /PRNewswire/ -- BONESUPPORT AB, an emerging leader in injectable bone substitutes for orthopedic trauma, bone infections and instrument augmentation related to orthopedic surgery, today announced that a comprehensive review article summarizing available published and presented data for composite products containing calcium sulphate and hydroxyapatite, extensively refers to preclinical studies and clinical applications published on CERAMENT(TM)|BONE VOID...

2013-10-28 23:23:00

Study was presented at the Combined Orthopaedic Research Society Meeting in Venice, Italy. Lund, Sweden (PRWEB) October 28, 2013 BONESUPPORT AB, an emerging leader in injectable bone substitutes for orthopedic trauma, bone infections and instrument augmentation related to orthopedic surgery, announced results from a five-year follow-up study on patients treated with CERAMENT™|BONE VOID FILLER, as presented at the Combined Orthopaedic Research Society (CORS) meeting in Venice, Italy. The...

2013-10-22 23:22:02

One of the world’s leading online suppliers of dermal fillers has launched new products. Bridgeport, CT (PRWEB) October 22, 2013 Representatives with Juveni Dermal Fillers announced today the launching of its latest products: Juveni CAHA and Juveni PLLA. “We’re extremely excited about the launching of these products,” said Stephanie Gering, spokesperson for Juveni Dermal Fillers. CAHA 30 percent, according to Gering, provides an injectable implant, similar to, but without the cost...

2013-10-22 04:22:57

NEW YORK, Oct. 22, 2013 /PRNewswire/ -- A United States Patent has been issued for Growth Factor(TM)-9's growth hormone boosting compound. United States Patent Number 8,551,542 has been issued to protect Growth Factor-9's oral growth hormone boosting compound as "Methods and compositions for increasing growth hormones." The background of the patent says, "The primary biological function of human growth hormone (hGH) includes stimulating growth, cell repair and regeneration. Once...

2013-10-17 04:21:28

NYON, Switzerland, October 17, 2013 /PRNewswire/ -- On World Osteoporosis Day, October 20, the International Osteoporosis Foundation (IOF) is calling for women to take action now to protect their bone health. Broken bones due to osteoporosis often result in pain, immobility and loss of quality of life as well as early death. In women over 45 years of age, osteoporosis accounts for more days spent in hospital than many other diseases, including diabetes, heart attack or breast...

2013-10-14 08:25:20

Local foot surgeon urges patients not to ignore foot pain SAN ANTONIO, Oct. 14, 2013 /PRNewswire/ -- Unexplained foot fractures may be the first sign of osteoporosis, a bone thinning disease which affects over 28 million Americans and accounts for 1.5 million bone fractures a year. According to San Antonio foot and ankle surgeon Eddie Davis, DPM, FACFAS, osteoporosis is frequently referred to as the "silent crippler" since it often progresses without any symptoms or isn't diagnosed...

2013-10-07 08:24:49

--Study is First to Analyze All Relevant Clinical Trials of Oral and Intranasal Calcitonin in Women-- BALTIMORE and PHILADELPHIA, Oct. 7, 2013 /PRNewswire/ -- Tarsa Therapeutics, Inc. today announced that it presented a new meta-analysis showing that salmon calcitonin does not appear to be associated with an increased risk of cancer in postmenopausal women. The meta-analysis was conducted using data derived from approximately 11,000 women in 24 randomized, controlled calcitonin trials that...

2013-10-03 04:20:05

Tsukuba, Japan, Oct 3, 2013 - (ACN Newswire) - Titanium (Ti) and its alloys are the most popular materials used in orthopedic implants because of their good mechanical and chemical properties, biocompatibility, corrosion resistance and low allergenicity. One drawback, however, is that they cannot bond directly to living bone, but need to be coated with bioactive materials to improve their integration.Calcium phosphate (CaP) and collagen are the main constituents of natural bone, and therefore...

2013-10-01 23:34:05

Triangle Orthopaedic Associates' recent acquisition of a state-of-the-art Hologic Discovery DXA system allows their practice to offer a low-cost alternative to expensive body scans at medical research centers. Durham, NC (PRWEB) October 01, 2013 Triangle Orthopaedics is raising the bar in bone health imaging. Triangle Orthopaedics’ multispecialty practice has recently acquired a new state-of-the-art DXA bone densitometer. Unprecedentedly, this particular machine, the Discovery...